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To Size or Not to Sized
There Is No Question
Balloon Sizing for Transcatheter Aortic Valve
Replacement*
Vasilis Babaliaros, MD
Atlanta, Georgia
When the association of paravalvular leak (PVL) and
increased mortality was ﬁrst described in 2012 at the 2-year
PARTNER I presentation (1), the transcatheter aortic valve
replacement (TAVR) community reacted with great concern
that this promising technology was beginning to show signs
of weakness. Since then, a great deal of data has been re-
ported from multiple registries conﬁrming this association.
Despite this research, a causal relationship between PVL
and mortality has not been proved, and the most effective
method of preventing PVL is still unknown.See page 965The relationship of PVL and mortality is somewhat
perplexing because even mild PVL has been associated with
increased mortality. Although the majority of TAVR cases
have some PVL post-implantation, it is important to note
that the vast majority of these patients do well. As a result,
most investigators have considered PVL that is “more-than-
mild” as signiﬁcant. The problem with these analyses is that
the amount of PVL is based on qualitative echocardio-
graphic observation. The pitfall of a qualitative echocardio-
graphic approach is that the interobserver variability prevents
true standardization. This variability likely has resulted in
downgrading the amount of PVL actually present. Causal
data have not yet been published regarding PVL and mor-
tality, but anecdotal experience from high-volume operators
has been reported at meetings, and moderate to severe PVL
that is corrected by transcatheter repair resolves the symp-
toms of heart failure in TAVR patients. Newer indexes that
quantify PVL, including aortic regurgitation (AR index),
Pressure gradient between diastolic aortic pressure and left
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may help clarify this issue. Our center routinely uses cardiac
magnetic resonance imaging to measure the aortic regur-
gitant fraction after TAVR.
Although the degree of aortic calciﬁcation and correct
placement of the transcatheter heart halve (THV) are
important, the most important and modiﬁable cause of PVL
is inappropriate sizing of the aortic annulus. Historically, the
selection of the appropriate THV size has been based on 2-
dimensional annular measurements using echocardiography.
Due to the limitations inherent in 2-dimensional imaging,
echocardiography was quickly surpassed by 3-dimensional
computed tomography (CT) annular measurements, now
considered the gold standard for valve sizing. Anecdotal data
and registry data from high-volume centers suggested that
optimal ﬁt requires 10% to 15% oversizing of the annulus
area by the balloon-expandable THV (2); however, this has
not been validated in a prospective trial or a retrospective
comparative trial. Comparing current with historical data
(PARTNER I), more-than-mild PVL has been decreased
from 12% using 2-dimensional echocardiography to 7.5%
using CT (3) and <5% in other series. The selection of self-
expanding valves has been largely based on CT scan cir-
cumference that also targets a 15% oversize. The risk of
signiﬁcantly oversizing is annular rupture, aortic hematoma,
or heart block.
Although the CT revolution has been sweeping the
TAVR community, there are a few investigators who have
championed the idea that the balloon used during aortic
valvuloplasty can be used as a valve sizer, similar to that used
by a surgeon before surgical aortic valve replacement. The
advantage of such a technique is that balloon valvuloplasty is
part of most TAVR procedures and that the sizing can be
directly determined rather than indirectly measured using
only imaging. The idea was ﬁrst described by our group
using balloon pressure measurements (4,5), but gained
popularity when balloon sizing with concomitant angiog-
raphy was described by Alain Cribier and Helene Eltch-
aninoff, personal communication, 2010. This version of the
technique was considerably simpler and thus disseminated
successfully during proctoring of cases outside the United
States and Canada. The idea was that a stop-ﬂow diameter
could be established and help differentiate annulus size in
borderline cases. It also allowed on-table decisions and
obviated the need for larger contrast loads that were
prohibitive in patients with renal insufﬁciency (w20% of
cases).
Patsalis et al. (6) from the West German Heart Center in
Essen, Germany carefully describe their experience with
balloon sizing and aortography, with a retrospective compar-
ison with their earlier experience using conventional echocar-
diography sizing. The incidence of more-than-mild PVL was
decreased from 14.4% to 7.8% without increasing the risk of
stroke, transient ischemic attack, native aortic insufﬁciency, or
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973annular damage. The decrease in PVL was associated with
a signiﬁcant decrease in mortality at 1 year, from 20% to
10.6%. For the ﬁrst time, a technique used for the correct
selection of THV was shown to affect both PVL and perhaps
mortality, and the authors are to be commended.
So what are the technical caveats? First, the balloons need
to be measured before they are used in order to be accurate.
Second, aortography needs to be done close to the aortic
valve commissures (the source of the leak). The pigtail
catheter is placed in the noncoronary cusp or at the sino-
tubular junction. The diameter of the THV should be the
same size as the balloon if contrast is power injected or the
THV should be 1 mm larger than the balloon diameter if
contrast is hand injected. Finally, even minimal leak around
the balloon should identify insufﬁcient size and indicate the
choice of the larger THV in borderline cases.
So do the outcomes reported by Patsalis et al. reﬂect
increasing experience or the incorporation of balloon sizing?
Certainly there is some bias toward better outcomes with
increasing experience; however, 39% of cases in the balloon-
sizing group were considered borderline by an experienced
operator. In this group, only 1 patient ended up with more-
than-mild PVL, despite choosing the smaller THV size in
25% of patients. Importantly, there is little down side to
balloon sizing, presumably because a more aggressive pre-
dilation with sizing decreased the need for post-dilation.
Does that mean balloon sizing, not CT, is the new gold
standard for THV size selection? Certainly, the technique of
balloon sizing and CT sizing are not adversarial but
complementary. Most TAVR operators can agree that
although the best method of sizing is not known, comple-
mentary techniques will corroborate the best THV size. In
a time of cost containment and resource utilization, tech-
niques such as balloon sizing and 3-dimensional echocar-
diography may fare better than cardiac CT.
TAVR devices continue to evolve rapidly, speciﬁcally
for repositionable and retrievable attributes. Perhaps theemphasis on valve sizing will become less intense as “1-shot”
devices are replaced with those that can be dynamically sized
and repositioned. The protocol for THV selection may also
change as the new shapes of self-expanding and balloon-
expandable devices with specialized skirts come to market.
For now, balloon sizing using one of the oldest forms of
imaging, cine-angiography, remains a worthy contributor to
the new world of TAVR.Reprint requests and correspondence: Dr. Vasilis Babaliaros,
Emory University Structural Heart and Valve Center, Emory
University Hospital, Suite F606, 1364 Clifton Road, Atlanta,
Georgia 30322. E-mail: vbabali@emory.edu.REFERENCES
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